Premium
Failure of Vitamin C to Affect the Pharmacokinetic Profile of Antipyrine in Man
Author(s) -
WILSON J. T.,
BOXTEL C. J.,
ALVAN G.,
SJOQVIST F.
Publication year - 1976
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/j.1552-4604.1976.tb02403.x
Subject(s) - volume of distribution , pharmacokinetics , vitamin , medicine , metabolism , plasma levels , plasma concentration , plasma clearance , distribution (mathematics) , endocrinology , oral administration , pharmacology , vitamin c , oral dose , mathematical analysis , mathematics
A possible interaction of vitamin C with the metabolism of drugs which are oxidized (e.g., antipyrine and diphenylhydantion) is indicated from data in animals. The effect of megadoses of vitamin C (300 mg/day to 4800 mg/day) was therefore tested in human volunteers receiving antiprine (single oral dose) or diphenlhydantoin (chronic therapy). The half-life, volume of distribution, and plasma clearance of antipyrine were not affected by vitamin C treatment. Steady-state plasma levels of diphenylhydantoin in two epileptic patients were similar before and during vitamin C (1.2 Gm/day for 18 days) treatment. It is concluded that vitamin C, in commonly used megadoses, has no effect on the metabolism of antipyrine or diphenylhydantoin in men.